Press Releases GT Medical Technologies Announces Launch of GammaTile® Center of Excellence Program and First Designation, USC Brain Tumor Center
Press Releases GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors
Press Releases GT Medical Technologies Achieves Two Clinical Milestones with GammaTile® to Help Treat Brain Tumors
Press Releases GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
Press Releases GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
Press Releases GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc.
Press Releases GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors
Press Releases GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc.
Press Releases GT Medical Technologies, Inc. Presents Use of GammaTile Therapy is Increasing in Time Across Several Brain Tumor Types at the 28th Annual Scientific Meeting and Education Day at the Society of Neuro-Oncology (SNO)
